Do you watch different functions blame each other for problems?

You’re not alone.

Problem: A recent client was bringing its first compound to Phase Two after decades of research on a new class of therapeutic agents. An investor deadline loomed for starting the dose-finding study.

Development was pushing to finalize the study but Research continued to oppose the design, insisting that the effect would disappear above a certain dose. Development found the arguments unconvincing. Research increasingly questioned the competence of the Development staff. Read more